Zelira Therapeutics Limited (ZLD.AX)
AUD 0.39
(-4.88%)
AUD 0.39
(-4.88%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 94.95 Thousand AUD | -68.47% |
| 2023 | 301.12 Thousand AUD | -80.45% |
| 2022 | 1.54 Million AUD | 132.26% |
| 2021 | 663.31 Thousand AUD | 0.0% |
| 2020 | - AUD | -100.0% |
| 2019 | 769.03 Thousand AUD | 145.1% |
| 2018 | 313.75 Thousand AUD | 213.63% |
| 2017 | 100.04 Thousand AUD | -66.65% |
| 2016 | 300 Thousand AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | -100.0% |
| 2010 | 34.25 Thousand AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | -100.0% |
| 2007 | 21.07 Million AUD | 14882.59% |
| 2006 | 140.69 Thousand AUD | -75.29% |
| 2005 | 569.47 Thousand AUD | 13.66% |
| 2004 | 501.04 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 40.22 Thousand AUD | 0.0% |
| 2024 Q2 | 54.72 Thousand AUD | 0.0% |
| 2024 FY | 94.95 Thousand AUD | -68.47% |
| 2023 Q4 | 224.17 Thousand AUD | 0.0% |
| 2023 FY | 301.12 Thousand AUD | -80.45% |
| 2023 Q2 | 76.94 Thousand AUD | 0.0% |
| 2022 FY | 1.54 Million AUD | 132.26% |
| 2022 Q2 | 727.69 Thousand AUD | 0.0% |
| 2022 Q4 | 812.92 Thousand AUD | 0.0% |
| 2021 Q2 | 90.5 Thousand AUD | 0.0% |
| 2021 FY | 663.31 Thousand AUD | 0.0% |
| 2021 Q4 | 572.81 Thousand AUD | 0.0% |
| 2020 Q4 | - AUD | 0.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2020 FY | - AUD | -100.0% |
| 2019 Q4 | 769.03 Thousand AUD | 0.0% |
| 2019 FY | 769.03 Thousand AUD | 145.1% |
| 2019 Q2 | - AUD | 0.0% |
| 2018 Q4 | 235.42 Thousand AUD | 0.0% |
| 2018 FY | 313.75 Thousand AUD | 213.63% |
| 2018 Q2 | 78.32 Thousand AUD | 0.0% |
| 2017 FY | 100.04 Thousand AUD | -66.65% |
| 2017 Q4 | 100.04 Thousand AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 Q4 | 50 Thousand AUD | 0.0% |
| 2016 Q1 | - AUD | 0.0% |
| 2016 Q2 | 250 Thousand AUD | 0.0% |
| 2016 Q3 | - AUD | -100.0% |
| 2016 FY | 300 Thousand AUD | 0.0% |
| 2015 Q3 | - AUD | 0.0% |
| 2015 Q1 | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2014 Q1 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 Q3 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 Q1 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 Q3 | - AUD | 0.0% |
| 2011 FY | - AUD | -100.0% |
| 2011 Q2 | - AUD | -100.0% |
| 2011 Q1 | 8562.50 AUD | 0.0% |
| 2010 Q4 | 8562.50 AUD | 0.0% |
| 2010 Q3 | 8562.50 AUD | 0.0% |
| 2010 FY | 34.25 Thousand AUD | 0.0% |
| 2010 Q2 | 8562.50 AUD | 0.0% |
| 2010 Q1 | - AUD | 0.0% |
| 2009 Q2 | - AUD | 0.0% |
| 2009 Q1 | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q3 | - AUD | 0.0% |
| 2008 FY | - AUD | -100.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2008 Q3 | - AUD | 0.0% |
| 2008 Q1 | 5.26 Million AUD | 0.0% |
| 2008 Q2 | - AUD | -100.0% |
| 2007 FY | 21.07 Million AUD | 14882.59% |
| 2007 Q1 | 35.17 Thousand AUD | 0.0% |
| 2007 Q2 | 5.26 Million AUD | 14882.91% |
| 2007 Q3 | 5.26 Million AUD | 0.0% |
| 2007 Q4 | 5.26 Million AUD | 0.0% |
| 2006 FY | 140.69 Thousand AUD | -75.29% |
| 2006 Q2 | 35.17 Thousand AUD | -75.3% |
| 2006 Q3 | 35.17 Thousand AUD | 0.0% |
| 2006 Q1 | 142.36 Thousand AUD | 0.0% |
| 2006 Q4 | 35.17 Thousand AUD | 0.0% |
| 2005 Q2 | 142.36 Thousand AUD | 13.66% |
| 2005 Q1 | 125.26 Thousand AUD | 0.0% |
| 2005 Q4 | 142.36 Thousand AUD | 0.0% |
| 2005 Q3 | 142.36 Thousand AUD | 0.0% |
| 2005 FY | 569.47 Thousand AUD | 13.66% |
| 2004 Q4 | 125.26 Thousand AUD | 0.0% |
| 2004 FY | 501.04 Thousand AUD | 0.0% |
| 2004 Q3 | 125.26 Thousand AUD | 0.0% |
| 2004 Q2 | 125.26 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AdAlta Limited | 1.73 Million AUD | 94.536% |
| Acrux Limited | 5.09 Million AUD | 98.135% |
| Race Oncology Limited | 4 Million AUD | 97.628% |
| Biome Australia Limited | 13 Million AUD | 99.27% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 84.223% |
| BTC Health Limited | 16.36 Thousand AUD | -480.391% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 98.727% |
| CSL Limited | 22.41 Billion AUD | 100.0% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 99.175% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 99.892% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 99.857% |
| Hexima Limited | - AUD | -Infinity% |
| Immutep Limited | 3.5 Million AUD | 97.292% |
| Memphasys Limited | 60 Thousand AUD | -58.253% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 99.959% |
| Noxopharm Limited | 2.4 Million AUD | 96.044% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 97.442% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | 68.268% |
| Starpharma Holdings Limited | 8.28 Million AUD | 98.854% |
| Tissue Repair Ltd | 152.24 Thousand AUD | 37.63% |
| Biotron Limited | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 97.638% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -418.297% |
| Patrys Limited | 1.39 Million AUD | 93.189% |
| Orthocell Limited | 5.31 Million AUD | 98.214% |
| Imugene Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 22.05 Million AUD | 99.57% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | 89.357% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 95.9% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -458.541% |
| Nanollose Limited | 12.5 Thousand AUD | -659.555% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 92.167% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 97.868% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 92.413% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.981% |
| Dimerix Limited | 583.47 Thousand AUD | 83.727% |
| PharmAust Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | 79.376% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -44.304% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | 79.949% |
| Actinogen Medical Limited | 9.93 Million AUD | 99.044% |
| Immuron Limited | 4.9 Million AUD | 98.063% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 96.345% |